Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 16.

Order by Relevance | Date

Total 852 results found since Jan 2013.

Zimbabwe: Minister Launches Cancer Vaccination Scheme
[New Zimbabwe]THE government has introduced the human papilloma virus (HPV) vaccine in an effort to reduce cervical cancer deaths among women.
Source: AllAfrica News: Health and Medicine - September 16, 2014 Category: African Health Source Type: news

HPV urine test could screen for cervical cancer
Conclusion This systematic review and meta-analysis indicates that urine tests for detecting HPV DNA might be feasible for screening women for cervical cancer based on an evidence base of 14 diverse studies involving 1,443 women. While it is feasible this type of test might be useful for screening, there were many limitations in the evidence base reviewed. This means its effectiveness as a screening tool is still up for debate and is unproven. Issues include: the large variation between individual studies for participant characteristics the large variation in estimates of test sensitivity and specificity between ind...
Source: NHS News Feed - September 17, 2014 Category: Consumer Health News Tags: Cancer Medical practice Source Type: news

Keeping up with immunizations for adults
This paper discusses recommendations from the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices for vaccinating adults against influenza, tetanus, measles, mumps, rubella, varicella, hepatitis A and B, human papillomavirus, shingles (zoster), pneumonia, and meningitis.
Source: Cleveland Clinic Journal of Medicine - October 1, 2014 Category: Journals (General) Authors: NIELSEN, C. Tags: Medical Grand Rounds Source Type: research

Mozambique: Health Ministry Confident on HPV Vaccination Target
[AIM]Maputo -The Mozambican Health Ministry is confident that it will reach the target for the third and final dose of vaccination against HPV, the human papilloma virus, which causes cervical cancer.
Source: AllAfrica News: Health and Medicine - October 28, 2014 Category: African Health Source Type: news

Human papillomavirus vaccination.
PMID: 25381861 [PubMed - in process]
Source: British Journal of Hospital Medicine - November 1, 2014 Category: Internal Medicine Authors: Brotherton JM Tags: Br J Hosp Med (Lond) Source Type: research

HPV vaccine rates perpetuate racial and geographic cancer disparities
SAN ANTONIO – Girls who live in states with higher rates of cervical cancer incidence and mortality are less likely to receive the human papilloma virus vaccine, researchers reported at a meeting on disparities in cancer health care held by the American Association for Cancer...
Source: Skin and Allergy News - November 11, 2014 Category: Dermatology Tags: FPN Journals FPN News FPN Child & Adolescent Medicine FPN Infectious Diseases IMN Journals IMN News Source Type: news

Provider-focused intervention improves HPV vaccination rates
Changing the way doctors practice medicine is difficult, however a new study has shown that combining traditional education with quality improvement and incentives improves Human Papilloma virus vaccination rates in boys and girls. The study has the potential to produce sustained improvements in these vaccination rates.
Source: ScienceDaily Headlines - November 24, 2014 Category: Science Source Type: news

HPV vaccine, riskier sexual activity not linked researchers say
(Queen's University) Sexual behavior of teenage girls does not appear to be impacted by the human papilloma virus (HPV) vaccine, according to Queen's researchers Drs. Leah Smith and Linda Lévesque.
Source: EurekAlert! - Medicine and Health - December 8, 2014 Category: Global & Universal Source Type: news

MD Anderson applauds FDA approval of HPV vaccine
(University of Texas M. D. Anderson Cancer Center) The Food and Drug Administration's approval of a new vaccine that targets five additional strains of human papilloma virus fortifies a proven cancer-prevention weapon, according to Ronald A. DePinho, M.D., president of The University of Texas MD Anderson Cancer Center.
Source: EurekAlert! - Medicine and Health - December 11, 2014 Category: Global & Universal Source Type: news

FDA Approves Merck's HPV Vaccine, GARDASIL®9, to Prevent Cancers and Other Diseases Caused by Nine HPV types – Including Types that Cause About 90% of Cervical Cancer Cases
Dateline City: KENILWORTH, N.J. GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Deb Wambold, 215-652-2913orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker:...
Source: Merck.com - Product News - December 11, 2014 Category: Drugs & Pharmacology Tags: Prescription Medicine News Vaccine News Corporate News Latest News Source Type: news

Anorectal Human Papillomavirus: Current Concepts.
Authors: Assi R, Reddy V, Einarsdottir H, Longo WE Abstract Increased anorectal human papillomavirus (HPV) infection is related to the recent trends in sexual behavior in both homosexual and heterosexual groups and prevalence of infection with human immunodeficiency virus (HIV). Clinical presentation and natural history depend on the serotype involved. HPV 6 and 11 are found in the benign wart. Local control can be achieved with a wide selection of surgical and topical techniques. HPV 16, 18, and 31 are found in dysplastic lesions and have the potential to progress to invasive anal squamous cell carcinoma. Recognit...
Source: The Yale Journal of Biology and Medicine - December 18, 2014 Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research

January Cervical Cancer Month: Progress Is Promising
January is Cervical Cancer Month. So it is time to look at what has been accomplished recently in control of this disease. Getting treatment for advanced cervical cancer is challenging. Patients often have pelvic pain, sometimes with blockage of intestines and the urinary tract. Regrettably many patients have fistulas (holes) develop where they leak urine or stool through the skin, vagina or bladder. These are cruel consequences of failed cancer control. About 13,000 women will develop cervical cancer every year, and tragically 4,000 will die of the illness. In 2014, the FDA approved a new treatment for advanced cervical...
Source: Healthy Living - The Huffington Post - January 9, 2015 Category: Consumer Health News Source Type: news

HIV infection and domestic smoke exposure, but not human papillomavirus, are risk factors for esophageal squamous cell carcinoma in Zambia: a case–control study
Abstract There is emerging evidence that esophageal cancer occurs in younger adults in sub‐Saharan Africa than in Europe or North America. The burden of human immunodeficiency virus (HIV) is also high in this region. We postulated that HIV and human papillomavirus (HPV) infections might contribute to esophageal squamous cell carcinoma (OSCC) risk. This was a case–control study based at the University Teaching Hospital in Lusaka, Zambia. Cases were patients with confirmed OSCC and controls had completely normal upper endoscopic evaluations. A total of 222 patients were included to analyze the influence of HIV infection;...
Source: Cancer Medicine - January 1, 2015 Category: Cancer & Oncology Authors: Violet Kayamba, Allen C. Bateman, Akwi W. Asombang, Aaron Shibemba, Kanekwa Zyambo, Themba Banda, Rose Soko, Paul Kelly Tags: Original Research Source Type: research

Human Papillomavirus Vaccine and Sexual Activity How Do We Best Address Parent and Physician Concerns?
Compared with other routinely recommended adolescent vaccines (eg, diphtheria and tetanus toxoids and acellular pertussis [Tdap] vaccine and quadrivalent meningococcal conjugate [MCV4] vaccine), human papillomavirus (HPV) vaccine uptake has been lower, with only 57% of adolescent females and 35% of adolescent males initiating the 3-dose HPV vaccine series. Often, the reasons cited for these low HPV vaccination rates pertain to the vaccine’s role in preventing a sexually transmitted infection (STI). Parents commonly indicate that they have not had their children vaccinated against HPV because the vaccine is not needed or ...
Source: JAMA Internal Medicine - February 9, 2015 Category: Internal Medicine Source Type: research

Incidence of Sexually Transmitted Infections After Human Papillomavirus Vaccination Among Adolescent Females
ImportanceHuman papillomavirus (HPV) vaccination rates among US females remain low, in part because of concerns that HPV vaccination may promote unsafe sexual activity by lowering perceived risks of acquiring a sexually transmitted infection (STI).ObjectiveTo study whether HPV vaccination of females is associated with increases in STI rates.Design, Setting, and ParticipantsUsing a large, longitudinal insurance database of females aged 12 to 18 years insured from January 1, 2005, through December 31, 2010, in the United States, we examined whether HPV vaccination was associated with an increase in incident STIs among female...
Source: JAMA Internal Medicine - February 9, 2015 Category: Internal Medicine Source Type: research